{"created":"2023-05-15T15:02:31.924503+00:00","id":84787,"links":{},"metadata":{"_buckets":{"deposit":"1c2d1812-8647-4570-8593-2869b50a609d"},"_deposit":{"created_by":1,"id":"84787","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"84787"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00084787","sets":["1"]},"author_link":["1043278","1043284","1043276","1043281","1043274","1043282","1043283","1043279","1043280","1043277","1043275","1043273"],"item_8_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2021-11","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"11","bibliographicPageEnd":"5642","bibliographicPageStart":"5635","bibliographicVolumeNumber":"41","bibliographic_titles":[{"bibliographic_title":"Anticancer research"}]}]},"item_8_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Background/Aim: To evaluate the outcomes of proton beam therapy (PBT) for early-stage non-small cell lung cancer (NSCLC) in patients with interstitial lung disease (ILD). Patients and Methods: Between 2002 and 2017, 110 patients receiving hypofractionated PBT for cT1-2N0M0 NSCLC were reviewed.\nResults: Of the 110 patients, 17 were diagnosed with ILD. The median follow-up period was 37.8 months. No significant difference in the 1-year cumulative rate of grade ≥2 pneumonitis was observed between patients with and those without ILD (17.6% vs. 14.1%, p=0.708). The lung doses were significantly lower in patients with than in those without ILD among patients without grade ≥2  neumonitis. There were no significant differences in overall survival or local recurrence-free rates according to the presence of ILD. Conclusion: PBT appears to be a feasible and effective treatment for cT1-2N0M0 NSCLC in\npatients with ILD, but the lung dose should be strictly reduced.","subitem_description_type":"Abstract"}]},"item_8_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"International Institute of Anticancer Research"}]},"item_8_relation_13":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"34732436","subitem_relation_type_select":"PMID"}}]},"item_8_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10.21873/anticanres.15379","subitem_relation_type_select":"DOI"}}]},"item_8_relation_17":{"attribute_name":"関連サイト","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://ar.iiarjournals.org/content/41/11/5635","subitem_relation_type_select":"URI"}}]},"item_8_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0250-7005","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Saito, Takashi"}],"nameIdentifiers":[{"nameIdentifier":"1043273","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ohnishi, Kayoko"}],"nameIdentifiers":[{"nameIdentifier":"1043274","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ishikawa, Hitoshi"}],"nameIdentifiers":[{"nameIdentifier":"1043275","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Nakamura, Masatoshi"}],"nameIdentifiers":[{"nameIdentifier":"1043276","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Hoshiai, Sodai"}],"nameIdentifiers":[{"nameIdentifier":"1043277","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Numajiri, Haruko"}],"nameIdentifiers":[{"nameIdentifier":"1043278","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Nemoto Murofushi, Keiko"}],"nameIdentifiers":[{"nameIdentifier":"1043279","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Mizumoto, Masashi"}],"nameIdentifiers":[{"nameIdentifier":"1043280","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Okumura, Toshiyuki"}],"nameIdentifiers":[{"nameIdentifier":"1043281","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Sakurai, Hideyuki"}],"nameIdentifiers":[{"nameIdentifier":"1043282","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Hitoshi, Ishikawa","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"1043283","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Hideyuki, Sakurai","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"1043284","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease"}]},"item_type_id":"8","owner":"1","path":["1"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-12-15"},"publish_date":"2021-12-15","publish_status":"0","recid":"84787","relation_version_is_last":true,"title":["Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T17:20:15.452401+00:00"}